BIOTRADING
CHETODRAL 10 SACHETS
CHETODRAL 10 SACHETS
Secure payment
Discreet and sanitized package
Fast and safe shipping
Description
Description
Chetodral
Chetodral is a dietary supplement containing vitamins B1, B2, and B6, mixed sugars, prebiotic glucooligosaccharides, sodium citrate, and potassium citrate, characterized by a cola flavor and aroma. Chetodral's carefully formulated formula effectively combats ketosis and acetone-induced vomiting in children and adults, and acts on multiple levels to address the complex metabolic changes that occur during acidosis.
Ingredients
Mixed sugars, tribasic sodium citrate, tribasic potassium citrate; vitamins: B1, B2, B6; bioecolians (glucooligosaccharide with prebiotic action).
Gluten free.
How to use
We recommend taking 2-3 sachets per day as needed or under medical advice.
Warnings
Do not exceed the recommended daily dose.
Conservation
Shelf life of intact packaging: 36 months.
Format
Pack containing 10 sachets of 8 g.
BIOTRADING
CHETODRAL 10 SACHETS
CHETODRAL 10 SACHETS
Couldn't load pickup availability
Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.
